Literature DB >> 22067541

Neurological diseases and pain.

David Borsook1.   

Abstract

Chronic pain is a frequent component of many neurological disorders, affecting 20-40% of patients for many primary neurological diseases. These diseases result from a wide range of pathophysiologies including traumatic injury to the central nervous system, neurodegeneration and neuroinflammation, and exploring the aetiology of pain in these disorders is an opportunity to achieve new insight into pain processing. Whether pain originates in the central or peripheral nervous system, it frequently becomes centralized through maladaptive responses within the central nervous system that can profoundly alter brain systems and thereby behaviour (e.g. depression). Chronic pain should thus be considered a brain disease in which alterations in neural networks affect multiple aspects of brain function, structure and chemistry. The study and treatment of this disease is greatly complicated by the lack of objective measures for either the symptoms or the underlying mechanisms of chronic pain. In pain associated with neurological disease, it is sometimes difficult to obtain even a subjective evaluation of pain, as is the case for patients in a vegetative state or end-stage Alzheimer's disease. It is critical that neurologists become more involved in chronic pain treatment and research (already significant in the fields of migraine and peripheral neuropathies). To achieve this goal, greater efforts are needed to enhance training for neurologists in pain treatment and promote greater interest in the field. This review describes examples of pain in different neurological diseases including primary neurological pain conditions, discusses the therapeutic potential of brain-targeted therapies and highlights the need for objective measures of pain.

Entities:  

Mesh:

Year:  2011        PMID: 22067541      PMCID: PMC3281476          DOI: 10.1093/brain/awr271

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  378 in total

Review 1.  Transcranial magnetic simulation in the treatment of migraine.

Authors:  Richard B Lipton; Starr H Pearlman
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

2.  Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.

Authors:  Robert H Dworkin; Mark P Jensen; Arnold R Gammaitoni; David O Olaleye; Bradley S Galer
Journal:  J Pain       Date:  2006-09-01       Impact factor: 5.820

Review 3.  Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability.

Authors:  I Jon Russell; Karen G Raphael
Journal:  CNS Spectr       Date:  2008-03       Impact factor: 3.790

Review 4.  Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera.

Authors:  Lars Arendt-Nielsen; David Yarnitsky
Journal:  J Pain       Date:  2009-04-19       Impact factor: 5.820

Review 5.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

6.  Injury of the spino-thalamo-cortical pathway is necessary for central post-stroke pain.

Authors:  Ji Heon Hong; Dai Seg Bai; Jin Young Jeong; Byung Yun Choi; Chul Hoon Chang; Seong Ho Kim; Sang Ho Ahn; Sung Ho Jang
Journal:  Eur Neurol       Date:  2010-08-10       Impact factor: 1.710

Review 7.  Pain associated with multiple sclerosis: systematic review and proposed classification.

Authors:  Alec B O'Connor; Steven R Schwid; David N Herrmann; John D Markman; Robert H Dworkin
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

8.  Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam.

Authors:  Ralph-Thomas Kiefer; Peter Rohr; Annette Ploppa; Karl-Heinz Altemeyer; Robert Jay Schwartzman
Journal:  Pain Pract       Date:  2007-06       Impact factor: 3.183

9.  Pain intensity on and off levodopa in patients with Parkinson's disease.

Authors:  Angelika Nebe; Georg Ebersbach
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

Review 10.  Fibromyalgia and psychiatric disorders.

Authors:  Pierluigi Fietta; Pieranna Fietta; Paolo Manganelli
Journal:  Acta Biomed       Date:  2007-08
View more
  61 in total

Review 1.  What about pain in disorders of consciousness?

Authors:  C Schnakers; C Chatelle; A Demertzi; S Majerus; S Laureys
Journal:  AAPS J       Date:  2012-04-18       Impact factor: 4.009

Review 2.  The perception of pain and its management in disorders of consciousness.

Authors:  Francesca Pistoia; Simona Sacco; Marco Sarà; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2013-11

3.  SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases.

Authors:  Subodh Kumar Mishra; Neha Jain; Uma Shankar; Arpita Tawani; Amit Mishra; Amit Kumar
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

4.  Guest editorial: Opportunities in rehabilitation research.

Authors:  Alexander K Ommaya; Kenneth M Adams; Richard M Allman; Eileen G Collins; Rory A Cooper; C Edward Dixon; Paul S Fishman; James A Henry; Randy Kardon; Robert D Kerns; Joel Kupersmith; Albert Lo; Richard Macko; Rachel McArdle; Regina E McGlinchey; Malcolm R McNeil; Thomas P O'Toole; P Hunter Peckham; Mark H Tuszynski; Stephen G Waxman; George F Wittenberg
Journal:  J Rehabil Res Dev       Date:  2013

5.  HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex.

Authors:  John R Keltner; Colm G Connolly; Florin Vaida; Mark Jenkinson; Christine Fennema-Notestine; Sarah Archibald; Cherine Akkari; Alexandra Schlein; Jisu Lee; Dongzhe Wang; Sung Kim; Han Li; Austin Rennels; David J Miller; George Kesidis; Donald R Franklin; Chelsea Sanders; Stephanie Corkran; Igor Grant; Gregory G Brown; J Hampton Atkinson; Ronald J Ellis
Journal:  Pain Med       Date:  2017-03-01       Impact factor: 3.750

Review 6.  Review of Treatment for Central Spinal Neuropathic Pain and Its Effect on Quality of Life: Implications for Neuromyelitis Optica Spectrum Disorder.

Authors:  Maureen A Mealy; Sharon L Kozachik; Michael Levy
Journal:  Pain Manag Nurs       Date:  2019-05-15       Impact factor: 1.929

7.  Cyane-carvone, a synthetic derivative of carvone, inhibits inflammatory response by reducing cytokine production and oxidative stress and shows antinociceptive effect in mice.

Authors:  Thiago Henrique Costa Marques; Maria Leonildes Boavista Gomes Castelo Branco Marques; Jand-Venes R Medeiros; Renan Oliveira Silva; André Luiz dos Reis Barbosa; Tamires Cardoso Lima; Damião Pergentino de Sousa; Rivelilson Mendes de Freitas
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

8.  Orthopedic Injured versus Uninjured Comparison Groups for Neuroimaging Research in Mild Traumatic Brain Injury.

Authors:  Elisabeth A Wilde; Ashley L Ware; Xiaoqi Li; Trevor C Wu; Stephen R McCauley; Amanda Barnes; Mary R Newsome; Brian D Biekman; Jill V Hunter; Zili D Chu; Harvey S Levin
Journal:  J Neurotrauma       Date:  2018-10-10       Impact factor: 5.269

9.  HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.

Authors:  John R Keltner; Christine Fennema-Notestine; Florin Vaida; Dongzhe Wang; Donald R Franklin; Robert H Dworkin; Chelsea Sanders; J Allen McCutchan; Sarah L Archibald; David J Miller; George Kesidis; Clint Cushman; Sung Min Kim; Ian Abramson; Michael J Taylor; Rebecca J Theilmann; Michelle D Julaton; Randy J Notestine; Stephanie Corkran; Mariana Cherner; Nichole A Duarte; Terry Alexander; Jessica Robinson-Papp; Benjamin B Gelman; David M Simpson; Ann C Collier; Christina M Marra; Susan Morgello; Greg Brown; Igor Grant; J Hampton Atkinson; Terry L Jernigan; Ronald J Ellis
Journal:  J Neurovirol       Date:  2014-02-19       Impact factor: 2.643

Review 10.  Modulation of pain, nociception, and analgesia by the brain reward center.

Authors:  Vasiliki Mitsi; Venetia Zachariou
Journal:  Neuroscience       Date:  2016-05-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.